Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1981 3
1983 2
1984 1
1985 5
1986 3
1987 12
1988 4
1989 8
1990 3
1991 4
1992 4
1993 7
1994 10
1995 8
1996 12
1997 11
1998 21
1999 23
2000 32
2001 25
2002 30
2003 34
2004 37
2005 33
2006 42
2007 33
2008 42
2009 48
2010 56
2011 60
2012 56
2013 56
2014 64
2015 71
2016 57
2017 45
2018 85
2019 68
2020 73
2021 93
2022 73
2023 75
2024 25

Text availability

Article attribute

Article type

Publication date

Search Results

1,268 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean t budd (1,203 results)?
Boosting CAR T cells with anti-tumor mRNA vaccines.
Chehrazi-Raffle A, Budde LE, Pal SK. Chehrazi-Raffle A, et al. Nat Med. 2023 Nov;29(11):2711-2712. doi: 10.1038/s41591-023-02623-x. Nat Med. 2023. PMID: 37932550 No abstract available.
eHealth in transplantation.
Duettmann W, Naik MG, Zukunft B, Osmonodja B, Bachmann F, Choi M, Roller R, Mayrdorfer M, Halleck F, Schmidt D, Budde K. Duettmann W, et al. Transpl Int. 2021 Jan;34(1):16-26. doi: 10.1111/tri.13778. Epub 2020 Nov 27. Transpl Int. 2021. PMID: 33111393 Free article. Review.
Conversion from Calcineurin Inhibitor- to Belatacept-Based Maintenance Immunosuppression in Renal Transplant Recipients: A Randomized Phase 3b Trial.
Budde K, Prashar R, Haller H, Rial MC, Kamar N, Agarwal A, de Fijter JW, Rostaing L, Berger SP, Djamali A, Leca N, Allamassey L, Gao S, Polinsky M, Vincenti F. Budde K, et al. J Am Soc Nephrol. 2021 Dec 1;32(12):3252-3264. doi: 10.1681/ASN.2021050628. Epub 2021 Dec 1. J Am Soc Nephrol. 2021. PMID: 34706967 Free PMC article. Clinical Trial.
BACKGROUND: Calcineurin inhibitors (CNIs) are standard of care after kidney transplantation, but they are associated with nephrotoxicity and reduced long-term graft survival. Belatacept, a selective T cell costimulation blocker, is approved for the prophylaxis of kidney tr …
BACKGROUND: Calcineurin inhibitors (CNIs) are standard of care after kidney transplantation, but they are associated with nephrotoxicity and …
Bendamustine vs. fludarabine/cyclophosphamide lymphodepletion prior to BCMA CAR-T cell therapy in multiple myeloma.
Sidana S, Hosoya H, Jensen A, Liu L, Goyal A, Hovanky V, Sahaf B, Bharadwaj S, Latchford T, Arai S, Leahy S, Mei M, Budde LE, Muffly LS, Frank MJ, Dahiya S, Htut M, Miklos D, Janakiram M. Sidana S, et al. Blood Cancer J. 2023 Oct 13;13(1):158. doi: 10.1038/s41408-023-00929-0. Blood Cancer J. 2023. PMID: 37833271 Free PMC article. No abstract available.
CD8(+) T Cell-Mediated Neuronal Dysfunction and Degeneration in Limbic Encephalitis.
Ehling P, Melzer N, Budde T, Meuth SG. Ehling P, et al. Front Neurol. 2015 Jul 15;6:163. doi: 10.3389/fneur.2015.00163. eCollection 2015. Front Neurol. 2015. PMID: 26236280 Free PMC article. Review.
While effects of plasma cell-derived antibodies on neuronal function and integrity are increasingly becoming characterized, potentially contributing effects of T cell-mediated immune mechanisms remain poorly understood. CD8(+) T cells are known to directly interact …
While effects of plasma cell-derived antibodies on neuronal function and integrity are increasingly becoming characterized, potentially cont …
T cells expressing CD123 chimeric antigen receptors for treatment of acute myeloid leukemia.
Mardiros A, Forman SJ, Budde LE. Mardiros A, et al. Curr Opin Hematol. 2015 Nov;22(6):484-8. doi: 10.1097/MOH.0000000000000190. Curr Opin Hematol. 2015. PMID: 26457961 Free PMC article. Review.
Immune-based therapies targeting CD123 are being developed. Preclinical data suggest that CD123 CAR T cells exhibit potent antileukemic activity and various impacts on normal hematopoiesis. SUMMARY: CD123 is an attractive surface target for novel antileukemic therapies. CD …
Immune-based therapies targeting CD123 are being developed. Preclinical data suggest that CD123 CAR T cells exhibit potent antileukem …
Long-Term Follow-Up of Bridging Therapies Prior to CAR T-Cell Therapy for Relapsed/Refractory Large B Cell Lymphoma.
Ladbury C, Dandapani S, Hao C, Fabros M, Amini A, Sampath S, Glaser S, Sokolov K, Yeh J, Baird JH, Kambhampati S, Herrera A, Mei M, Nikolaenko L, Shouse G, Budde LE. Ladbury C, et al. Cancers (Basel). 2023 Mar 14;15(6):1747. doi: 10.3390/cancers15061747. Cancers (Basel). 2023. PMID: 36980632 Free PMC article.
BACKGROUND: Bridging therapy (BT) with systemic therapy (ST), radiation therapy (RT), or combined-modality therapy (CMT) is increasingly being utilized prior to chimeric antigen receptor (CAR) T-cell therapy for large B-cell lymphoma (LBCL). We report the long-term outcome …
BACKGROUND: Bridging therapy (BT) with systemic therapy (ST), radiation therapy (RT), or combined-modality therapy (CMT) is increasingly bei …
1,268 results